FDA Drug Approval, N050341, FUNGIZONE
FDA Drug Approval, N050341, FUNGIZONE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 050341
Company: BRISTOL MYERS SQUIBB
Drug Name: FUNGIZONE
Active Ingredients: AMPHOTERICIN B
Strength: 100MG/ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 06/02/1971
Marketing Status: Discontinued
Submission Classification:
Company: BRISTOL MYERS SQUIBB
Drug Name: FUNGIZONE
Active Ingredients: AMPHOTERICIN B
Strength: 100MG/ML
Dosage Form/Route: SUSPENSION;ORAL
Action Date: 06/02/1971
Marketing Status: Discontinued
Submission Classification:
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details